In vivo microcomputed tomography visualization of a hepatocellular carcinoma orthotopic model using a contrast based on LaF3:Ce(5 %)Tb(15 %) nanoparticles
Authors:
- D. V. KhodakovaDKD. V. Khodakova
- A. S. GoncharovaAGA. S. Goncharova
- K. S. EreminKEK. S. Eremin
- S. V. GurovaSGS. V. Gurova
- Z. M. GadzhimagomedovaZGZ. M. Gadzhimagomedova
- O. E. PolozhentsevOPO. E. Polozhentsev
- A. V. GalinaAGA. V. Galina
- A. A. ShulgaASA. A. Shulga
- I. V. GolovinovIGI. V. Golovinov
- T. M. KecheryukovaTKT. M. Kecheryukova
Open Access
- 31 January 2025
- journal article
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 6 (1) , 32-40
Abstract
Purpose of the study. To investigate the effectiveness of a new contrast agent based on LaF3:Ce(5 %)Tb(15 %) nanoparticles on a hepatocellular carcinoma orthotopic model.Materials and methods. The experiment was performed on female BALB/c Nude mice. The subcutaneous model was created by injecting Hep G2 tumor cell culture into the right side of the animals. The orthotopic models were obtained by implanting a fragment of a subcutaneous Hep G2 xenograft into the left lobe of the liver of mice. Colloidal water solutions of LaF3:Ce(5 %)Tb(15 %) nanoparticles were prepared by dispersing the nanoparticle powder in bidistilled water using an ultrasonic tube for 30 minutes. Two samples with different nanoparticle sizes (13 and 60 nm) were administered to mice intravenously in a volume of 200 μl at a concentration of 40 mg/ml. The assessment of changes in radiopacity of the internal organs of animals was carried out at different points in time (before nanoparticle injection, at 5 min, 30 min, 1 h, 2 h, 4 h, 24 h, 48 h, and 7 days after inlection) using microcomputer tomography on a Quantum GX2 device. On the 7th day of the experiment, animals were euthanized by dislocation of the cervical vertebrae, organs (liver and spleen) were collected and fixed in a 10 % solution of neutral formalin. Sections for histological examination and their staining were made according to the standard method.Results. Microcomputer tomography (micro-CT) results indicated accumulation of both contrast samples in the spleen and healthy liver tissue within 5 minutes after intravenous injection, maintaining X-ray contrast for the 7-days. However, no specific accumulation of nanoparticles in the tumor was observed. Histological analysis revealed minimal impact on the liver structure and cells, with a more pronounced effect in the spleen.Conclusion. These findings suggest that LaF3:Ce(5 %)Tb(15 %) metal nanoparticles can be used in in vivo experiments for liver and spleen visualization after further investigation of their long-term effects.Keywords
This publication has 14 references indexed in Scilit:
- Animal Models in Cancer Research: Revolutionizing the Field of Oncology2024
- COMPARATIVE ASSESSMENT OF METHODS TO CREATE ORTHOTOPIC MODEL OF LIVER CANCERСовременные проблемы науки и образования (Modern Problems of Science and Education), 2023
- Trends of Hepatocellular Carcinoma (HCC) Inpatients Mortality and Financial Burden From 2011 to 2017Journal of Clinical Gastroenterology, 2022
- Hepatocellular cancer. Current aspects of carcinogenesisCLINICAL AND EXPERIMENTAL MORPHOLOGY, 2022
- Micro-CT for Biological and Biomedical Studies: A Comparison of Imaging TechniquesJournal of Imaging, 2021
- Advances in micro-CT imaging of small animalsPhysica Medica, 2021
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesCA: A Cancer Journal for Clinicians, 2021
- Metallic nanoparticles as X-Ray computed tomography (CT) contrast agents: A reviewJournal of Molecular Structure, 2020
- Biodistribution and in vivo toxicity of aptamer-loaded gold nanostarsNanomedicine: Nanotechnology, Biology and Medicine, 2015
- Pharmacokinetics of metallic nanoparticlesWIREs Nanomedicine and Nanobiotechnology, 2014